-
Mashup Score: 0Responses to the SARS-CoV-2 booster vaccination in patients with lymphoid malignancies - 2 year(s) ago
Here, we provide a summary of two papers investigating humoral and T-cell-mediated responses in patients with lymphoid malignancies receiving a third BNT162b2 vaccine dose.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1EMN recommendations for COVID-19 vaccination in patients with MM - 2 year(s) ago
Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of disease characteristics and comorbidities, or treatment-mediated immune suppression. With regard to the COVID-19 pandemic, this can translate to prolonged infection and an increased risk of mortality following infection with SARS-CoV-2.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👀 Catch up on this 👀 ❗ European Myeloma Network recommendations for #COVID19 vaccination in patients with multiple #myeloma ❗ 📚 Read a summary of the consensus guidelines on the Multiple Myeloma Hub. 👉 https://t.co/p15g48fzgN 👈 #mmsm #COVIDvaccine #SESCOVID #SESCOVID19 https://t.co/MfO2p6xOiY
-
-
Mashup Score: 0How do CAR T-cell recipients respond to COVID-19 vaccination? - 2 year(s) ago
During the 4th European CAR T-Cell Meeting, the Multiple Myeloma Hub was pleased to speak to Arnon Nagler, Sheba Medical Center, Tel Aviv, IL. We asked, how do CAR T-cell recipients respond to COVID-19 vaccination?
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📹 #CART22 | The Multiple #Myeloma Hub was pleased to speak to @nagler_EBMT, Sheba Medical Center, Tel Aviv, IL. We asked, how do CAR T-cell recipients respond to #COVID-19 vaccination ❓ #mmsm #SESCOVID #SESCOVID19 https://t.co/yxw6LPh9HX
-
-
Mashup Score: 0EMN recommendations for COVID-19 vaccination in patients with MM - 2 year(s) ago
Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of disease characteristics and comorbidities, or treatment-mediated immune suppression. With regard to the COVID-19 pandemic, this can translate to prolonged infection and an increased risk of mortality following infection with SARS-CoV-2.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
❗ European Myeloma Network recommendations for #COVID19 vaccination in patients with multiple #myeloma ❗ 📚 Read a summary of the consensus guidelines on the Multiple Myeloma Hub. 👉 https://t.co/p15g48fzgN 👈 #mmsm #COVIDvaccine #SESCOVID #SESCOVID19 https://t.co/LN4oRfyxVa
-
-
Mashup Score: 1COVID-19 lessons learnt in patients with multiple myeloma - 2 year(s) ago
During the 18th International Myeloma Workshop, Evangelos Terpos provided a summary of what has been learnt with respect to patients with multiple myeloma (MM) and COVID-19 so far.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👀 What do we know so far about patients with #myeloma and #COVID19? 📚 Read on to find out how infection affects patients and their response to vaccination 👇 #mmsm #SESCOVID #SESCOVID19 https://t.co/SjaRH7JK4J
-
-
Mashup Score: 0
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been significantly affected by this crisis at every stage of their treatment.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔔 In case you missed it! 💉 What’s the latest advice for transplant patients on #COVID19 vaccination? 👉 https://t.co/Q6lN8TPqQe 👈 #AML #AMLsm #SESCOVID19
-
-
Mashup Score: 1NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies - 3 year(s) ago
Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary recommendations issued by the National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee state that all cancer patients should be prioritized for COVID-19 vaccination, and caregivers and household/close contacts should also be considered for early immunizatio
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
⏰ In case you missed it! Preliminary recommendations for #COVID19Vaccine accination in cancer patients have been published by the @NCCN. 👀 #mmsm #COVID19 #SESCOVID19 https://t.co/YOcRC9TTSb
-
-
Mashup Score: 0NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies - 3 year(s) ago
Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary recommendations issued by the National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee state that all cancer patients should be prioritized for COVID-19 vaccination, and caregivers and household/close contacts should also be considered for early immunization.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📚 Have you read this article? Preliminary recommendations for #COVID19 vaccination in cancer patients have been published by the @NCCN 💉 👉 https://t.co/5CdL1tyvsg 👈 #SESCOVID19 #SARSCoV2 #COVID19Vaccine #Leusm #Leukemia
-
-
Mashup Score: 18Fungal superinfections and COVID-19 in the ICU - 3 year(s) ago
The COVID-19 pandemic has caused a worldwide healthcare crisis. In addition to the morbidity caused by the initial infection, severely ill patients are also at increased risk of secondary infections. During the 26th Congress of the European Hematology Association (EHA), Martin Hoenigl presented a talk that examined fungal superinfection in patients with severe COVID-19 infection in intensive care…
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🩺 How much of a problem are fungal superinfections for patients in the ICU with #COVID19, and how should they be treated? @martinhoenigl 👉 https://t.co/2PVqid19NQ 👈 #SESCOVID19 #amlsm #hematology #leusm #leukemia
-
-
Mashup Score: 5Fungal superinfections and COVID-19 in the ICU - 3 year(s) ago
The COVID-19 pandemic has caused a worldwide healthcare crisis. In addition to the morbidity caused by the initial infection, severely ill patients are also at increased risk of secondary infections. During the 26th Congress of the European Hematology Association (EHA), Martin Hoenigl presented a talk that examined fungal superinfection in patients with severe COVID-19 infection in intensive care…
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🩺 How much of a problem are fungal superinfections for patients in the ICU with #COVID19, and how should they be treated? @martinhoenigl 👉 https://t.co/bUsnJiQ72n 👈 #SESCOVID19 #lymsm #hematology
-
💉 Does a third SARS-CoV-2 booster vaccine improve humoral and T-cell-mediated immune responses in patients with lymphoid malignancies who failed to respond to their previous two doses? 👉 https://t.co/OzOJNOM3uk 👈 #lymsm #COVID19 #SESCOVID19 #lymphoma